EQUATE
OverviewSuggest Edit
EQUATE is a producer of petrochemicals. It offers polyethylene, ethylene glycol, styrene monomer, polypropylene, and paraxylene chemical products.
| Type | Private | |
| Founded | 1995 | |
| HQ | الأحمدي, KW | Map |
| Website | equate.com | |
| Employee Ratings |
Recent NewsAll News
- Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
- Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association
- Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience
Latest Updates
| Employees (est.) (Aug 2022) | 1,797 | (+2%) |
| Cybersecurity rating | B | More |
EQUATE Financials and Metrics
Summary Metrics
Founding Date | 1995 |
EQUATE Cybersecurity Score
EQUATE Online and Social Media Presence
17.95k Twitter followers
EQUATE has 17.95k Twitter Followers. The number of followers has increased 0.1% month over month and increased 0.4% quarter over quarter
EQUATE's Trends
Twitter Engagement Stats for @EQUATEofficial
4.2k
Tweets
11
Following
18k
Followers
18
Tweets last 30 days
2.7
Avg. likes per Tweet
72.2%
Tweets with engagement
EQUATE News and Updates
June 11, 2021
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
Itolizumab continues to demonstrate favorable safety and efficacy profile
May 13, 2021
Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association
LA JOLLA, Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that an abstract highlighting positive data from the EQUATE study of itolizumab in ac…
January 22, 2021
Equillium Announces Acceptance of Late-Breaking Abstract for Oral Presentation of Interim Data from EQUATE Study in acute GVHD at the 2021 TCT Meetings Digital Experience
LA JOLLA, Calif., Jan. 22, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ) a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, today announced that interim data from the Phase 1b/2 EQUATE study of itolizumab in acute graft-versu…
EQUATE Blogs
March 21, 2022
EQUATE Group partners with Kuwait Fire Force on new home safety campaign
Initiative raises awareness of fire hazard safety to keep Kuwait homes safe KUWAIT, March 21, 2022 — As part of its commitment to the health, safety and wellbeing of the communities in which it operates, EQUATE Group’s decade-long support of the Kuwait Fire Force (KFF) continues with its latest home…
February 21, 2022
EQUATE Group Announces Financial Results for 2021
KUWAIT, February 21, 2022 — The EQUATE Group, a global producer of petrochemicals and the world’s leading supplier of ethylene glycol announced its full-year earnings for 2021 this week, posting an increase in total revenues of 42 percent over 2020 results. EQUATE Group’s revenues in 2021 totaled U.…
January 09, 2022
EQUATE Sponsors 15th Gulf Petrochemicals and Chemicals Association Forum in Dubai. Redefine. Reshape. Reinvent’ – delegates discuss the chemical industry in a post-pandemic reality
KUWAIT, December 09, 2021 — The EQUATE Group, a global producer of petrochemicals and the world’s leading supplier of Ethylene Glycol, is an official sponsor of the 15th Annual Gulf Petrochemicals & Chemicals Association (GPCA) Forum in Dubai. The forum addresses the theme “Redefine. Reshape. Re…
October 12, 2021
EQUATE Publishes its 2019-2020 Sustainability Report Unveiling Advancement on Sustainability Initiatives
EQUATE Releases its 2019-2020 Sustainability Report Unveiling Advancements on Sustainability Initiatives Leading with agility to maximize growth and resilience amid the pandemic Kuwait, October 12th , 2021 — EQUATE Group, a global producer of petrochemicals, has published its seventh sustainability …
September 22, 2021
MEGlobal Americas Inc. Plans For 100 Per Cent Renewable Electricity at Oyster Creek Site by 2023
MEGlobal Americas Inc. Plans For 100 Per Cent Renewable Electricity at Oyster Creek Site by 2023 Sep 21st, 2021 OYSTER CREEK, TX – MEGlobal Americas Inc. (MEGlobal) has entered into an agreement with Calpine Energy Solutions, LLC to purchase renewable energy to fulfill 100 per cent of the expected …
August 31, 2021
EQUATE Group Announces Financial Results for First Half, 2021
KUWAIT, August 26, 2021 — The EQUATE Group, a global producer of petrochemicals and the world’s leading supplier of Ethylene Glycol announced its earnings for the first half of 2021. The EQUATE Group reported total revenue of US$2,041 million in H1 2021, compared to US$1,423 million during the same …
EQUATE Frequently Asked Questions
When was EQUATE founded?
EQUATE was founded in 1995.
How many employees does EQUATE have?
EQUATE has 1,797 employees.
Who are EQUATE competitors?
Competitors of EQUATE include Braskem, Taiheiyo Cement and Bostik.
Where is EQUATE headquarters?
EQUATE headquarters is located at Unnamed Road, الأحمدي.
Where are EQUATE offices?
EQUATE has an office in الأحمدي.
How many offices does EQUATE have?
EQUATE has 2 offices.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies